Wuxi Biologics (2269:HK) (WXXWY) PT Lowered to HK$93.60 at Goldman Sachs
Tweet
Share
E-mailGet Alerts 2269:HK Hot Sheet
Price: $0.00 --0%
Rating Summary:
0 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 16 | New: 24
Rating Summary:
0 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 16 | New: 24
Join SI Premium – FREE
Goldman Sachs analyst Ziyi Chen lowered the price target on Wuxi Biologics (2269:HK) (OTC: WXXWY) to HK$93.60 (from HK$95.00) while maintaining a Buy rating.
You May Also Be Interested In
- Proya Cosmetics Co Ltd (603605:CH) PT Lowered to RMB154.29 at CLSA
- IHH Healthcare (IHH:MK) (IHHHF) PT Lowered to MYR7.50 at CLSA
- NSK Ltd (6471:JP) (NPSKY) PT Raised to JPY850 at Nomura/Instinet
Create E-mail Alert Related Categories
Analyst Comments, Analyst PT Change, Intl RatingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
